Lantern Pharma
LTRN • NASDAQ • Stock Fundamentals
Lantern Pharma is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Panna Sharma, with a market cap of $43.1M.
Market Cap$43.1M
Employees21.0
CEOPanna Sharma
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 12, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Lantern Pharma FAQ
Common questions about Lantern Pharma
Lantern Pharma (LTRN) has a market capitalization of $43.1M and trades on NASDAQ.
Lantern Pharma has approximately 21 employees.